Intrapallidal metabotropic glutamate receptor activation in a rat model of Parkinson's disease: Behavioral and histological analyses

Takashi Agari, Takao Yasuhara, Toshihiro Matsui, Satoshi Kuramoto, Akihiko Kondo, Yasuyuki Miyoshi, Tetsuro Shingo, Cesario V. Borlongan, Isao Date

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Metabotropic glutamate receptors (mGluRs) have been recently implicated as robust therapeutic targets for Parkinson's disease (PD). Here, we explored how activation of mGluRs in globus pallidus (GP) affected the amphetamine-induced rotational behavior in the unilateral 6-hydroxydopamine (6-OHDA) lesion rat model of PD. The amphetamine-induced rotations were completely suppressed by the ipsilateral intrapallidal injection of the non-selective mGluR agonist, 1-aminocyclopentane-1S,3R-dicarboxylic acid (ACPD) and the selective group I mGluR agonist, (R,S)-3,5-dihydroxyphenylglycine (DHPG), but not the selective group III mGluR agonist, l-2-amino-4-phosphonobutyric acid (l-AP4). The suppressive effects were detected at 2, 4, 6, 8, and 12 h after ACPD injection, but returned to the control level at 24 h. A remarkable c-fos expression was found in the lesioned side of GP, subthalamic nucleus (STN), and substantia nigra pars reticulata (SNr) of rats that received the ACPD or DHPG injection, compared to rats treated with L-AP-4 or phosphate buffer-injection. The results indicate that the blockade of amphetamine-induced rotations might be at least partially mediated by group I mGluR activation. This study advances the use of selective group I mGluRs directed toward the GP for PD treatment.

Original languageEnglish
Pages (from-to)189-196
Number of pages8
JournalBrain Research
Volume1203
DOIs
Publication statusPublished - Apr 8 2008

Fingerprint

Metabotropic Glutamate Receptors
Dicarboxylic Acids
Globus Pallidus
Parkinson Disease
Amphetamine
Injections
Oxidopamine
Subthalamic Nucleus
Buffers
Phosphates
Therapeutics

Keywords

  • ACPD
  • Amphetamine
  • c-Fos
  • DHPG
  • Globus pallidus
  • mGluR

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Developmental Biology
  • Molecular Biology

Cite this

Intrapallidal metabotropic glutamate receptor activation in a rat model of Parkinson's disease : Behavioral and histological analyses. / Agari, Takashi; Yasuhara, Takao; Matsui, Toshihiro; Kuramoto, Satoshi; Kondo, Akihiko; Miyoshi, Yasuyuki; Shingo, Tetsuro; Borlongan, Cesario V.; Date, Isao.

In: Brain Research, Vol. 1203, 08.04.2008, p. 189-196.

Research output: Contribution to journalArticle

Agari, Takashi ; Yasuhara, Takao ; Matsui, Toshihiro ; Kuramoto, Satoshi ; Kondo, Akihiko ; Miyoshi, Yasuyuki ; Shingo, Tetsuro ; Borlongan, Cesario V. ; Date, Isao. / Intrapallidal metabotropic glutamate receptor activation in a rat model of Parkinson's disease : Behavioral and histological analyses. In: Brain Research. 2008 ; Vol. 1203. pp. 189-196.
@article{2c02e81bcbfa4fe48cad94881b3b02a1,
title = "Intrapallidal metabotropic glutamate receptor activation in a rat model of Parkinson's disease: Behavioral and histological analyses",
abstract = "Metabotropic glutamate receptors (mGluRs) have been recently implicated as robust therapeutic targets for Parkinson's disease (PD). Here, we explored how activation of mGluRs in globus pallidus (GP) affected the amphetamine-induced rotational behavior in the unilateral 6-hydroxydopamine (6-OHDA) lesion rat model of PD. The amphetamine-induced rotations were completely suppressed by the ipsilateral intrapallidal injection of the non-selective mGluR agonist, 1-aminocyclopentane-1S,3R-dicarboxylic acid (ACPD) and the selective group I mGluR agonist, (R,S)-3,5-dihydroxyphenylglycine (DHPG), but not the selective group III mGluR agonist, l-2-amino-4-phosphonobutyric acid (l-AP4). The suppressive effects were detected at 2, 4, 6, 8, and 12 h after ACPD injection, but returned to the control level at 24 h. A remarkable c-fos expression was found in the lesioned side of GP, subthalamic nucleus (STN), and substantia nigra pars reticulata (SNr) of rats that received the ACPD or DHPG injection, compared to rats treated with L-AP-4 or phosphate buffer-injection. The results indicate that the blockade of amphetamine-induced rotations might be at least partially mediated by group I mGluR activation. This study advances the use of selective group I mGluRs directed toward the GP for PD treatment.",
keywords = "ACPD, Amphetamine, c-Fos, DHPG, Globus pallidus, mGluR",
author = "Takashi Agari and Takao Yasuhara and Toshihiro Matsui and Satoshi Kuramoto and Akihiko Kondo and Yasuyuki Miyoshi and Tetsuro Shingo and Borlongan, {Cesario V.} and Isao Date",
year = "2008",
month = "4",
day = "8",
doi = "10.1016/j.brainres.2008.01.051",
language = "English",
volume = "1203",
pages = "189--196",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",

}

TY - JOUR

T1 - Intrapallidal metabotropic glutamate receptor activation in a rat model of Parkinson's disease

T2 - Behavioral and histological analyses

AU - Agari, Takashi

AU - Yasuhara, Takao

AU - Matsui, Toshihiro

AU - Kuramoto, Satoshi

AU - Kondo, Akihiko

AU - Miyoshi, Yasuyuki

AU - Shingo, Tetsuro

AU - Borlongan, Cesario V.

AU - Date, Isao

PY - 2008/4/8

Y1 - 2008/4/8

N2 - Metabotropic glutamate receptors (mGluRs) have been recently implicated as robust therapeutic targets for Parkinson's disease (PD). Here, we explored how activation of mGluRs in globus pallidus (GP) affected the amphetamine-induced rotational behavior in the unilateral 6-hydroxydopamine (6-OHDA) lesion rat model of PD. The amphetamine-induced rotations were completely suppressed by the ipsilateral intrapallidal injection of the non-selective mGluR agonist, 1-aminocyclopentane-1S,3R-dicarboxylic acid (ACPD) and the selective group I mGluR agonist, (R,S)-3,5-dihydroxyphenylglycine (DHPG), but not the selective group III mGluR agonist, l-2-amino-4-phosphonobutyric acid (l-AP4). The suppressive effects were detected at 2, 4, 6, 8, and 12 h after ACPD injection, but returned to the control level at 24 h. A remarkable c-fos expression was found in the lesioned side of GP, subthalamic nucleus (STN), and substantia nigra pars reticulata (SNr) of rats that received the ACPD or DHPG injection, compared to rats treated with L-AP-4 or phosphate buffer-injection. The results indicate that the blockade of amphetamine-induced rotations might be at least partially mediated by group I mGluR activation. This study advances the use of selective group I mGluRs directed toward the GP for PD treatment.

AB - Metabotropic glutamate receptors (mGluRs) have been recently implicated as robust therapeutic targets for Parkinson's disease (PD). Here, we explored how activation of mGluRs in globus pallidus (GP) affected the amphetamine-induced rotational behavior in the unilateral 6-hydroxydopamine (6-OHDA) lesion rat model of PD. The amphetamine-induced rotations were completely suppressed by the ipsilateral intrapallidal injection of the non-selective mGluR agonist, 1-aminocyclopentane-1S,3R-dicarboxylic acid (ACPD) and the selective group I mGluR agonist, (R,S)-3,5-dihydroxyphenylglycine (DHPG), but not the selective group III mGluR agonist, l-2-amino-4-phosphonobutyric acid (l-AP4). The suppressive effects were detected at 2, 4, 6, 8, and 12 h after ACPD injection, but returned to the control level at 24 h. A remarkable c-fos expression was found in the lesioned side of GP, subthalamic nucleus (STN), and substantia nigra pars reticulata (SNr) of rats that received the ACPD or DHPG injection, compared to rats treated with L-AP-4 or phosphate buffer-injection. The results indicate that the blockade of amphetamine-induced rotations might be at least partially mediated by group I mGluR activation. This study advances the use of selective group I mGluRs directed toward the GP for PD treatment.

KW - ACPD

KW - Amphetamine

KW - c-Fos

KW - DHPG

KW - Globus pallidus

KW - mGluR

UR - http://www.scopus.com/inward/record.url?scp=40949141823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40949141823&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2008.01.051

DO - 10.1016/j.brainres.2008.01.051

M3 - Article

C2 - 18313647

AN - SCOPUS:40949141823

VL - 1203

SP - 189

EP - 196

JO - Brain Research

JF - Brain Research

SN - 0006-8993

ER -